Nomura Holdings’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$570K Buy
+70,000
New +$635K ﹤0.01% 1325
2025
Q4
Sell
-196,600
Closed -$1.7M 2081
2025
Q3
$1.7M Buy
196,600
+96,600
+97% +$752K ﹤0.01% 1201
2025
Q2
$630K Buy
+100,000
New +$662K ﹤0.01% 1093

Other funds holding NVAX

Nomura Holdings's NVAX Position: Q1 2026 in Review

Nomura Holdings opened a new position in Novavax (NVAX) in Q1 2026: 90,896 shares worth $740K. The stake represents ﹤0.01% of the portfolio and ranks #1252 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in NVAX as recently as Q1 2025.

Nomura Holdings first reported a position in NVAX in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.95M in Q4 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Nomura Holdings held 90,896 shares of Novavax worth $740K as of Q1 2026.
  • Novavax was a new Nomura Holdings position in Q1 2026.
  • Novavax made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1252 holding.
  • Nomura Holdings first reported a position in Novavax in Q2 2013 and has held it in 15 quarters since.
  • Nomura Holdings's Novavax position peaked at $4.95M in Q4 2021.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.